Showing results (91-100 of 769) with videos related to
Sort By:
Pageof 77
Health Education & Behavior : the Official Publication of the Society for Public Health Education|April 21, 1998
The Healthy Neighborhoods Project: a local health department's role in catalyzing community developmentG el-Askari, J Freestone, C Irizarry, et al.Regulatory Toxicology and Pharmacology : RTP|November 8, 2011
Background incidence of liver chemistry abnormalities in pediatric clinical trials for conditions with and without underlying liver diseaseHeide A Stirnadel, Chanchal Bains, Mynepalli Lakshmi, et al.Acta Neuropathologica|October 25, 2000
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic miceM C Irizarry, B S Cheung, G W Rebeck, et al.Biophysical Journal|February 27, 1999
Dynamics of plaque formation in Alzheimer's diseaseB Urbanc, L Cruz, S V Buldyrev, et al.Archives of Neurology|June 11, 2008
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer diseaseJoseph J Locascio, Hiroaki Fukumoto, Liang Yap, et al.Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 2, 2022
Editorial Commentary: Real-Time Dynamic Magnetic Resonance Imaging of the Patellofemoral Joint: Ready for Prime Time?William R Walter, Christopher J BurkeHMO Practice|April 9, 1991
The emergency and after-hours care system at Group Health CooperativeJ R Walter, K S HubenetPsychiatry Research|April 26, 2003
Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysisLara L Davidson, R Walter HeinrichsComprehensive Psychiatry|August 28, 2004
Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neurolepticsTeresa L Sota, R Walter HeinrichsPageof 77